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ABSTRACT
Kappa opioid receptors are colocalized with dopamine receptors and are frequently
associated with depression, anxiety, stress, and drug use and abuse. KOR antagonism has
widely been considered anti-depressive and anxiolytic in animal models while agonism is
pro-depressive and anxiogenic. However, recent findings suggest that SalvA, a natural
kappa agonist derived from a plant in the mint family, can reduce depressive- and
anxiety-like behavior in rats. The current study investigated the effects of chronic mild
stress on behavior, attenuation by SalvA, and sex differences. 52 Long-Evans rats, 26
males and 26 females, were exposed to six weeks of CMS. Animals received daily
injections of either SalvA or vehicle for the last three weeks of the experiment.
Behavioral tests were administered at baseline, three weeks, and six weeks. We predicted
that CMS would induce the depressive-like behaviors anhedonia and learned
helplessness, as measured by reduced sucrose preference and increased immobility in the
forced swim test, respectively. We also predicted that CMS would induce anxiety-like
behavior by reducing exploratory behavior and increasing immobility in the open field
test. It was predicted that SalvA exposure would attenuate the effects of CMS. Further,
we predicted that female rats would be more sensitive to the effects of stress but also
show greater response to SalvA. Results showed that CMS did not reliably induce
depressive- or anxiety-like behaviors. Because there were no reliable behavioral changes
due to stress, the potential antidepressant or anxiolytic effects of SalvA were not
apparent. In the male drug group, SalvA appeared to increase anxious behavior in the
open field test and depressive-like behavior in the forced swim test, aligning with
previous findings that KOR agonists can be anxiogenic and pro-depressive. Additionally,
results showed that behavior in the forced swim and open field tests were sex dependent,
with males showing more depression- and anxiety-like behaviors than females. More
research is necessary to better understand the effects of CMS and SalvA on behavior.
Closer examination of the behavioral paradigms measuring depression and anxiety in
animals is needed and future research should carefully consider sex differences when
employing these behavioral paradigms.
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Influence of Salvinorin A and Sex Differences on Depressive- and AnxietyLike Behaviors in a Chronic Mild Stress Paradigm
The recent opioid crisis is escalating and with that comes the need for closer
examination of the comorbid relationships between psychiatric disorders, drug use, and
drug abuse. Of recent interest in the field is the role of the kappa opioid system and sex
differences in the quest to better understand major depressive disorder, anxiety disorders,
and addiction (Wee & Koob, 2010, Freeman, Naylor, Prisinzano, & Woolverton, 2014,
Chartoff & Mavrikaki, 2015).
The endogenous opioid system consists of three receptor subtypes: Mu (μ), Delta
(δ), and Kappa (κ). Opioid receptors are often colocalized with monoamine receptors,
suggesting that opioids play an important role in mood, pleasure, reward, and subsequent
influence on mood related disorders. Previously, research has focused on the mu opioid
system and the drugs that activate it, as they have increased abuse potential. In opposition
to the euphoria common with activation of the mu and delta opioid systems, the kappa
opioid system is often referred to as the “anti-reward system”. Kappa opioid receptor
(KOR) activation has, historically, been linked to feelings of dysphoria, the induction of
depressive-like and anxiety-like behaviors, and is commonly associated with stress, pain,
drug abuse and other psychopathologies. Stress and pain are well established risk factors
for drug abuse and relapse (Bockstaele, Reyes, & Valentino, 2010). Exposure to stress
and physical pain can induce the release of the endogenous kappa opioid receptor ligand,
dynorphin, in the nucleus accumbens (NAcc) and other brain areas associated with the
stress response (Bruchas, Land, & Chavkin, 2010).
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The NAcc plays an important role in stress response, reward, motivation and
depressive like behaviors (Pena, 2017). The neurons of the NAcc, primarily
dopaminergic (D1 and D2) medium spiny neurons, exhibit coexpression of D1 and
dynorphin and agonism of these KORs decreases dopamine levels (Donzanti, Althaus,
Payson, & Von Voigtlander, 1992, Ebner, Roitman, Potter, Rachlin, & Chartoff, 2010).
KOR activation via stimulation of dynorphinergic neurons in the NAcc core can induce
aversive behaviors (Al-Hasani, et al., 2015). KOR agonists also inhibit dopaminergic
neurons in the ventral tegmental area, which projects to the NAcc (Margolis, Hjelmstad,
Bonci, & Fields, 2003). Chronic KOR activation via a synthetic kappa agonist can induce
a significant increase in depressive-like symptoms, including anhedonia, in mice (Dogra,
Kumar, Umrao, Sahasrabuddhe, & Yadav, 2016). Salvinorin-A, a natural KOR agonist,
has been reported to upregulate DA reuptake and decrease DA release, resulting in prodepressive effects (Kivell, et al., 2015). Further, KOR activation has been shown to
modulate cocaine seeking, underscoring the role of KORs in the pro-addictive
components of stress exposure. This system has also been implicated in both
physiological and psychological responses to stress (Bruchas, Land, & Chavkin, 2010).
In summary, the literature suggests that kappa opioid and dopamine receptors are
colocalized in neurons of the NAcc and have modulating effects on each other. Chronic
stress can result in the release of dynorphin and subsequent inhibition of dopamine
neurons in this area, decreasing dopamine levels and providing a scaffold for the
development of mood disorders and drug seeking behaviors.
On the other hand, there is evidence suggesting that activation of KORs can be
antidepressant and anxiolytic, providing potential new therapeutic routes in the treatment
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of depression and anxiety. One possible explanation for discrepancies in the literature
may be related to dosage. For example, lower doses of a KOR agonist produced
anxiolytic effects in rats on the elevated plus maze test, where those treated with the
agonist had increased open arm entries compared to controls (Privette & Terrian, 1995).
A KOR agonist also attenuated learned helplessness, a common symptom of depression,
in a foot shock paradigm (Ukai, Suzuki, & Mamiya, 2002). Activation of dynorphinergic
neurons in specific regions of the NAcc shell can result in rewarding effects and place
preference (Al-Hasani, et al., 2015). A majority of the research on the KOR system
utilizes exogenous dynorphin administration, endogenous dynorphin release by streas or
pain, or other synthetic KOR agonists and antagonists.
Contemporary trends in the field have turned to the natural, exogenous KOR
agonist, Salvinorin-A. While synthetic KOR agonists usually result in pro-depressive
effects, SalvA exhibits complex influences on brain chemistry and behavior.
Administration of Salvinorin-A can induce both anti- and pro-depressive effects.
(Harden, Smith, Niehoff, McCurdy, & Taylor, 2012, Braida, et al., 2009).
Salvia Divinorum is a plant in the mint family. The psychoactive ingredient,
Salvinorin-A (SalvA), is reported to be initially dysphoric and hallucinogenic, with
increased mood (euphoria) post hallucination in humans (Baggott, Erowid, Erowid,
Galloway & Mendelson, 2010). SalvA is thought to be unique because it is the only
known naturally occurring KOR agonist, while other kappa agents used in research are
synthetic, lab created agonists or antagonists. SalvA has high affinity for and selectively
binds to KORs, with little affinity for catecholamine or serotonin receptors, which are

EFFECT OF SALVINORIN A, SEX, AND STRESS ON BEHAVIOR

7

common targets of anti-depressants. Moreover, SalvA is a lipid, whereas most KOR
binding ligands are amine agents.
Previous research found that SalvA can produce anxiolytic and anti-depressive
effects in animal models using the elevated plus maze, forced swim test, and sucrose
preference (Braida et al., 2009, Harden, Smith, Niehoff, McCurdy, & Taylor, 2012).
SalvA also has the ability to increase NAcc dopamine release and produce rewarding
effects in an intracerebroventricular self-administration and conditioned place preference
paradigm, however these effects were dose dependent (Braida, et al., 2007). Together,
data suggests that SalvA has unique properties as a KOR agonist, potentially opening
new doors for the development of effective treatments for anxiety, depression, and drug
abuse. However, it is important to explore the complex actions of SalvA in order to better
understand how it can influence behavior and mental health.
It has been well-established that women are more often diagnosed with major
depression than men. Previous findings in animal models of chronic mild stress (CMS)
revealed that dopamine and 5-HT activity were decreased in female, but not male, rats
(Dalla, et al., 2005, Dalla, et al., 2008). These results suggested that females may show
increased sensitivity to CMS and therefore, the onset of depressive-like symptoms. In
contrast, one study reported that female rats were less sensitive to the depressive-like
effects of a KOR agonist (Russell, et al., 2015). These depressive effects were not due to
sex differences in pharmokinetics, as concentration of the KOR agonist in the brain did
not differ. Moreover, intracranial self-stimulation, another common measure of
responsiveness to reward, in female rats did not differ depending on stage of the estrous
cycle, suggesting circulating gonadal hormones were not responsible for the sex
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differences in sensitivity to effects of the KOR agonist. Recent findings revealed
increased expression of the DA precursor, tyrosine hydroxylase, in the female ventral
tegmental area. This finding in conjunction with evidence of enhanced dopamine
synthesis may suggest a resiliency to dopamine suppression by KOR activation in
females (Conway, et al., 2019). Research from Walker et al., 2000, suggested that
increased dopamine in the female NAcc may also be a protective factor against KOR
activation induced dopamine inhibition.
Although depression and anxiety are more often reported in women than in men,
the majority of animal studies are conducted on male rodents. The main reason for this
discrepancy is the estrous cycle and hormonal fluctuations at its different stages are often
considered a potential confound. A 2014 meta-analysis of 293 animal studies indicated
that female mice were no more variable than males, regardless of estrous cycle stage
(Prendergast, Onishi, & Zucker, 2014). I argue that conducting research on female
rodents as they naturally cycle increases the translational reliability to humans.
The aim of the current study was to close the gap in the literature concerning the
role of kappa opioids in mood disorders and addiction. Specifically, the current study
investigated the unique KOR agonist SalvA and its potential as an anti-depressant and
anxiolytic agent. It also examined the influence of sex differences on the development of
depressive-like behaviors as well as recovery from these behaviors after SalvA exposure.
Hypothesis 1: I predicted that chronic mild stress would induce depressive-like
and anxiety-like behaviors in rats.
1a. Chronic mild stress would increase immobility in the forced swim test
compared to baseline.
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1b. CMS would increase immobility and time spent in the periphery in the
open field test compared to baseline.
1c. CMS would reduce sucrose preference compared to baseline
preference.
Hypothesis 2: I predicted the unique features of SalvA would make it effective in
reversing the effects of CMS.
2a. SalvA would attenuate immobility in the forced swim test.
2b. SalvA would reduce immobility and time spent in the periphery in the
open field test.
2c. SalvA would restore sucrose preference.
Hypothesis 3: I predicted that female rats would show an exaggerated response to
CMS but also increased recovery via SalvA compared to males.
Methods:
Experimental design
A total of 52 Long-Evans rats, 26 males and 26 females, were individually housed
as per standard laboratory procedure. Rats were assigned to one of four groups: male
control, male drug, female control, or female drug. Main factors for the 2 x 2 x 3 factorial
analysis were sex (male or female), drug condition (drug or vehicle) and timepoint of
behavioral tests (baseline, week three, and week six). Behavioral data was collected at
baseline, three weeks, and six weeks. Stressors were applied randomly for the full sixweek experiment while drug or vehicle were administered only during the final threeweek period. There was a total of seven replications of the study.
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Procedures
Chronic Unconditioned Mild Stress: Chronic mild stress is a common method
used to induce depressive- and anxiety-like behaviors in animals (Taylor, Cabrera, &
Hoffman, 2014). All animals received the same stressors for six weeks. Common
stressors in the chronic mild stress paradigm were used. Stressors included food
deprivation, water deprivation, home cage tilted at a 45° angle, bedding wet with 200ml
of water, and placement in the soiled cage of another rat. Alteration of normal day/night
light cycles, overnight illumination, and continuous illumination were also used as
stressors. All stressors were maintained for between 12 and 24 hours.
Behavioral Measures
Forced Swim Test: The forced swim test is a behavioral measure that assesses
learned helplessness, a common symptom of MDD. Learned helplessness is displayed by
animals as immobility in the forced swim test (Bogdanova, Kanekar, D'Anci, &
Renshaw, 2013). To assess learned helplessness, animals were placed in a 60.96cm x
25.4cm x 25.4cm clear glass cylinder with 45.72cm of room temperature (~25°c) water.
All animals were exposed to the testing environment for six minutes as an acclimation
period the day before baseline. Animal movements were recorded, and videos were
analyzed to determine the percent of time spent immobile during the test.
Open Field Testing: Emotionality is considered organic, expressive reactions to
a situation. Open field activity and emotionality are related, as emotional rats are less
active and exploratory than non-emotional animals (Doyle & Yule, 1959). The open field
test is a behavioral measure of both general locomotor activity and anxiety-like behaviors
(Bowman, Ferguson, & Luine, 2002). Animals that exhibit increased anxiety-like
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symptoms are expected to spend more time around the perimeter of the apparatus
compared to the center. Additionally, immobility is a commonly used passive response in
animals to threatening stimuli (Archer, 1976). Changes in immobility in studies of
anxiolytics confirm that immobility is a valid model of fear and anxiety (Hard, Engel,
Larsson, & Musi, 1986). Animals were placed in the center of a 67cm x 67cm x 42.5cm
clear acrylic apparatus and allowed to explore freely during a 10-minute trial. Data was
recorded using Anymaze© software to determine the ratio of time spent in the perimeter
versus the center of the apparatus and time spent immobile during the 10-minute trial. All
animals were exposed to the open field apparatus for 30 minutes to get acclimated to the
testing environment prior to baseline.
Anhedonia: Anhedonia, a common symptom of major depressive disorder, is
characterized by motivational dysregulation and decreased feelings of reward (Taylor,
Cabrera, & Hoffman, 2014). Anhedonia was measured using sucrose preference, whereas
reduced preference for sucrose water is associated with increased anhedonic behavior.
Bottles of 1% sucrose were prepared with 10g of granulated white cane sugar per 1 liter
of water. Sucrose water was presented alongside tap water in identical bottles, zip tied
together, and placed on the cage lid 5cm apart with nozzles at equal level to assure equal
ease of access. Animals were allotted access to both bottles for 24 hours. All animals
were sucrose naive and were exposed to the sucrose solution for a 24-hour acclimation
period before baseline testing.
Materials
Salvia in a powdered form (Sigma Aldrich, St. Louis, Missouri, USA) was
solubilized 75% dimethyl sulfoxide and 25% saline solution (0.9%) for injection. The
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solution was injected subcutaneously daily for three weeks at 0.3mg per kg/ body weight.
Control Animals received saline injections.
Statistical Analyses
Forced Swim Test
A 3-way ANOVA was conducted to determine the effects of sex, drug group, and
time point on immobility in the forced swim test, as measured by percent of time spent
immobile during the last 240 seconds of the swim period. There was a simple main effect
of time point, F(1, 48) = 4.921, p < 0.01. Post-hoc analyses revealed a significant
difference between baseline (M = 41.32 SD = 26.71) and week 6 (M = 57.29 SD = 22.60)
in the male drug group, p < 0.05 and between week 3 (M = 41.04 SD = 26.71) and week 6
(M = 57.29 SD = 22.60) in the male drug group, p < .05 (see Figure 1A).
There was a simple main effect of drug group, F(1, 48) = 8.798, p < 0.01. Posthoc analyses revealed a significant difference between the male control group (M = 76.19
SD = 17.46) and the male drug group (M = 41.32 SD = 26.71) at baseline, p < 0.001,
between the male control group (M = 77.98 SD = 24.33) and the male drug group (M =
41.04 SD = 26.71) at week 3, p < 0.001, and between the male control group (M = 80.06
SD = 24.29) and the male drug group (M = 57.29 SD = 22.60) at week 6, p < 0.05 (see
figure 1B).
A

B
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There was a simple main effect of sex, F(1, 48) = 15.060, p < 0.001. Males (M =
63.50 SD = 1.90) spent significantly more time immobile than females (M = 42.70 SD =
1.40). There was no significant 3-way interaction of sex by drug group by time point,
F(2, 96) = 0.409, p = 0.665. There was no 2- way interaction of sex by time point, F(2,
96) = 0.867, p = 0.423 or drug group by time point, F(2, 96) = 2.041, p = 0.135.
There was a significant 2-way
interaction of sex by drug group, F(1, 48)
= 10.724, p < 0.01. Post-hoc analyses
revealed a significant difference between
the male control group (M = 76.19 SD =
17.46) and female control group (M =
42.26 SD = 15.79) at baseline, p < 0.001, a
significant difference between the male control group (M = 77.98 SD = 24.33) and female
control group (M = 40.18 SD = 11.65) at week 3, p < 0.001, and a significant difference
between the male control group (M = 80.06 SD = 24.29) and female control group (M =
43.45 SD = 20.95) at week 6, p < .001 (see figure 2).
Open Field Test
A 3-way ANOVA was conducted to determine the effects of sex, drug group, and
time point on the open field test, measured as time spent in the periphery compared to the
center of the apparatus. There was a significant main effect of sex, F(1, 48) = 5.689, p <
0.05. There was a significant difference between the male control group (M = 592.14 SD
= 13.14) and the female control group (M = 579.06 SD = 20.97) at baseline, p < 0.01 (see
figure 3A).
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There was a significant main effect of time point, F(2, 96) = 9.649, p < 0.001.
There was a significant difference between baseline (M = 579.06 SD = 20.97) and week 3
(M = 589.21 SD = 11.49) in the female control group, p < 0.01, a significant difference
between baseline (M = 579.06 SD = 20.97) and week 6 (M = 588.95 SD = 8.51) in the
female control group, p < 0.01, and a significant difference between baseline (M = 586.23
SD = 15.35) and week 6 (M = 595.72 SD = 72) in the male drug group, p < 0.05 (see
figure 3A,B).
There was no significant 3-way interaction of sex by drug group by time point
F(2, 96) = 1.464, p = 0.236. There was no 2- way interaction of sex by time point, F(2,
96) = 0.241, p = 0.786. There was no 2- way interaction of drug group and time point
F(2, 96) = 0.119, p = 0.888. There was no 2-way interaction of sex and drug group F(1,
48) = 3.613, p = 0.063.
A 3-way ANOVA was conducted to determine the effects of sex, drug group, and
time point on immobility in the open field test, measured as time spent immobile
compared to total time in the open field apparatus. There was a significant main effect of
sex F(1, 48) = 9.891, p < 0.01. Post-hoc analyses revealed a significant difference
A

B
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between the male control group (M =
372.88 SD = 57.02) and the female
control group (M = 286.88 SD = 69.61)
at baseline, p < 0.01, a significant
difference between the male control
group (M = 409.46 SD = 44.57) and the
female control group (M= 314.52 SD =
137.27) at week 3, p < 0.01, and a significant difference between the male control group
(M = 396.00 SD = 62.05) and the female control group (M = 318.58 SD = 101.56) at
week 6, p < 0.05 (see figure 4).
There was a significant main effect of time point, F(2, 96) = 5.039, p < 0.01. Posthoc analyses revealed a significant difference between baseline (M= 322.72 SD = 83.63)
and week 3 (M = 361.01 SD = 95.15) and between baseline (M = 322.72 SD = 83.63) and
week 6 (M = 354.15 SD = 81.03), both p < 0.01. There was no significant main effect of
drug group, F(1, 48) = 0.226, p = 0.636. There was a no significant 3-way interaction of
sex by drug group by time point F(2, 96) = 1.573, p = 0.212. There was no 2- way
interaction of sex by time point F(2, 96) = 0.637, p = 0.532, drug group by time point
F(2, 96) = 0.136, p = 0.873, or sex by drug group F(1, 96) = 3.536, p = 0.066.
Sucrose Preference
A 3-way ANOVA was conducted to determine the effects of sex, drug group, and
time point on sucrose preference, measured as amount of sucrose solution consumed
compared to tap water. There was no main effect of sex, F(1, 48) = 0.815, p = 0.371 or
drug group, F(1, 48) = 1.492, p = 0.228.
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There was a significant main effect of time point, F(2, 96) = 13.792, p < 0.001.
Post-hoc analyses revealed a significant difference between baseline (M = 77.57 SD=
14.73) and week 6 (M = 95.38 SD = 6.48) in the female control group, p < 0.01, between
baseline (M = 74.97 SD = 20.10) and week 6 (M = 90.36 SD = 9.46) in the male drug
group, p < 0.05, and between baseline (M = 78.96 SD = 8.13) and week 6 (M = 93.24 SD
= 9.20) in the female drug group, p < 0.05. There was no significant 3-way interaction of
sex by drug group by time point, F(2, 96) = 1.218, p = 0.300. There was no 2-way
interaction of sex and drug group, F(1, 48) = 1.989, p = 0.165, sex by time point, F(2, 96)
= 0.415, p = 0.661, or drug group by time point, F(2, 96) = 0.267, p = 0.766.
A

B

C

Discussion
This study investigated the development of depressive- and anxiety-like behaviors
after exposure to chronic mild stress and recovery with SalvA, as well as sex differences
impacting these behaviors.
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The first hypothesis was that chronic mild stress (CMS) would induce depressive
and anxiety-like behaviors in rats. I predicted that CMS would increase immobility in the
forced swim test compared to baseline. This was not the case, as there was no significant
difference between baseline and week 3 for any group, implying that learned helplessness
was not displayed after three weeks of CMS. There were also no significant differences
between week 3 and week 6 for either control group, indicating no effect of CMS on
immobility. In the male drug group, there was a difference between baseline and week 6
and week 3 and week 6, however, it is impossible to determine if the differences seen
were due to the effects of stress or SalvA exposure.
There were, however, sex differences in the forced swim test. Results showed that
the male control group spent more time immobile than the female control group at
baseline, week 3, and week 6. This may suggest that males show higher trait immobility
at baseline and may be more sensitive to the effects of CMS. The sex differences in the
forced swim test seen in the present study are not in agreement with the third proposed
hypothesis that females would be more sensitive to the effects of CMS. This finding is,
however, consistent with previous research showing that females are more active in the
forced swim test than males (Alonso, Castellano, Afonso, & Rodriguez, 1991). Other
studies have concluded that, in response to stressful stimuli, females use more active
responses while males use more passive behavior, like immobility, which may explain
the sex differences seen here (Padilla, Barrett, Shumake, & Gonzalez-Lima, 2009).
I predicted that SalvA would attenuate immobility in the forced swim test. In
contrast to my hypothesis, there were no significant differences within the female drug
group. The male drug group spent significantly more time immobile at week 6 than week
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3 and at baseline. Because there was no change in immobility between baseline and week
3, the change between week 3 and week 6 cannot reliably be attributed to SalvA. In short,
there was no effect of CMS to be reversed by SalvA. In fact, the increase in immobility
between weeks 3 and 6 and might suggest anxiogenic instead of anxiolytic properties of
SalvA in males. Another possible explanation is that the drug had no effect and the
increase in immobility was due to the three additional weeks of CMS.
There were between group differences in the forced swim test. The male control
group spent more time immobile than the male drug group at baseline, week 3 and at
week 6. The former is an unexpected difference, specifically because the two male
groups showed behavioral differences before the drug was administered. This difference
in baseline anxiety between male groups is interesting and deserves further exploration.
The validity of the forced swim test as a measure of depressive behavior has been
questioned in the literature. Forced swimming is sometimes used as a stressor as opposed
to as a test of the effects of stress. For example, a 2016 review concluded that forced
swimming is a stressor and immobility is a passive and adaptive evolutionary response to
cope with that acute stress. The authors suggested that the forced swim test should not be
used to identify depression rat models (Kloet & Molendijk 2016).
I hypothesized that CMS would increase periphery time and immobility time in
the open field test compared to baseline. The female control group spent more time in the
periphery at week 3 and at week 6 than at baseline. Although this agrees with my
hypothesis that CMS would increase anxiety-like behaviors over time, there was no
significant increase from week 3 to week 6. Habituation to chronic stress is dependent on
multiple factors, including stress severity (Herman, 2013). Because we used a mild stress
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paradigm, it is plausible that the female control group reached a point of habituation after
week 3. Although there was a trend towards increased periphery time, there were no
significant differences between baseline and week 3 or week 3 and week 6. As such, it is
unclear whether the increase in anxiety-like behavior between baseline and week 6 was
due to the effects of CMS or SalvA. Additionally, the female drug group spent more time
in the periphery after CMS exposure but it did not reach significance.
The male control group spent more time in the periphery of the open field than the
female control group at baseline, which may suggest a higher baseline level of anxiety in
males. This finding is contrary to my hypothesis, based on previous findings, that females
would be more sensitive to the effects of CMS. However, it is concurrent with research
reporting male rats spent more time immobile and were more anxious in the open field
test than females (Kokras, et al., 2011). Another study found that male rats exposed to
CMS showed reduced exploratory activity while females displayed increased exploratory
behaviors (Horst, Wichmann, Gerrits, Westenbroek, & Lin, 2009).
The hypothesis that SalvA would reduce anxiety in the open field test was
rejected. There were no significant reductions in time in the periphery or immobility after
drug exposure. The male drug group spent more time in the periphery at week 6 than at
baseline. This might suggest that either SalvA produced and anxiogenic effect in males or
the effects of CMS weren’t apparent until closer to six weeks of stress exposure. The
female drug group showed less time in the periphery after SalvA exposure, but it did not
reach significance.
There were sex differences in the open field test. The male control group spent
more time immobile than the female control group at baseline, week 3, and week 6. This
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might suggest that males have a higher baseline level of anxiety. There is also the
potential that males were more susceptible to the effects of stress than females, which
would oppose my hypothesis that females would be more vulnerable to CMS. However,
previous research reported that non-stressed males are less active than females in the
open field test (Broadhurst, 1957, Denenberg & Morton, 1964). The finding that male
controls spent more time in the periphery than female controls at week 3 and week 6
could also be a result of the habituation to stress by females discussed earlier.
I predicted that CMS would result in anhedonic behavior as measured by reduced
sucrose preference. This hypothesis was rejected. The female control group preferred
sucrose more at week 6 than at baseline. There was a trend towards a greater preference
for sucrose at week 3 than at baseline, but the difference failed to achieve statistical
significance. Overall, the female control group showed an increase in sucrose preference
from baseline after 3 and 6 weeks of stress, opposite to what was expected. The male
drug group also preferred sucrose more at week 6 than at baseline, again, in the opposite
direction of our hypothesis.
Because results showed an overall trend towards increase in preference instead of
reduced preference, there was no apparent effect of CMS to be reversed by SalvA. Thus,
the hypothesis that SalvA would recover sucrose preference was rejected. According to a
study by Forbes, Stewart, Matthews, and Reid (1996), food deprivation was necessary to
decrease sucrose consumption in a CMS paradigm. Decreased consumption was also
associated with reduced body weight. Findings indicated that reduced sucrose preference
was independent of the stress paradigm and it was concluded that sucrose preference may
not be a valid measure of reward responsiveness. Additionally, results of a study by
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Wang, et al., 2009, suggested that in the chronic mild stress model of depression, it takes
three to five weeks for anhedonic behavior to normalize. Thus, expected results may have
been attained if the paradigm was longer than six weeks and animals were exposed to
SalvA for longer than three weeks.
In the present study, CMS failed to produce depressive-like behavior in the forced
swim test and sucrose preference test. CMS produced anxiety-like behavior in the open
field test but only in the female control group and it was not maintained after three
weeks. Because there was no reliable effect of stress, there was no change in behavior for
SalvA to reverse. In the female drug group, there was a trend towards an increase in
anxiety in the open field after CMS and then a return to baseline after SalvA exposure,
but unfortunately it did not reach significance. So, it appears that SalvA failed to reliably
reverse immobility in the forced swim test, reduce anxious behaviors in the open field
test, and restore sucrose preference when in fact the fault may fall on the CMS paradigm.
CMS has a history of poor reproducibility and inter-laboratory reliability
(Deussing, 2006, Nestler, Gould, & Manji, 2002). Although we followed a schedule of
stressors similar to those in other, successful studies, it is possible that our stressors were
not intense enough to produce the desired results. Future direction should focus on
perfecting the CMS paradigm in order to reliably produce a depressed state in animals.
Because CMS failed to produce the expected behaviors, it is difficult to determine
if any true drug effects were seen. Based on previous findings that SalvA can be
anxiolytic at low doses, we chose to use a low dose. The chosen dose may have been too
low to produce an effect. Further research should be carried out on the dose dependency
of SalvA. In addition, anhedonic behavior takes more than three weeks to normalize after
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introduction of an antidepressant agent. Therefore, extending the paradigm past six weeks
would give increased exposure to the drug and may increase the chance of more
significant drug effects.
The effects of SalvA on behavior in animal models has been hotly debated. In this
case, and specifically for the male drug group, the data seemed to coincide with other
labs that found SalvA to be pro-depressive and anxiogenic. Future research should
continue to examine the complex nature of SalvA and the kappa opioid system as a whole
in relation to stress, depression, anxiety. It is also necessary to better understand the
intricate relationship between sex differences and behavior in the chronic mild stress
paradigm. The critique of the validity of the forced swim and sucrose preference test
combined with issues surrounding reproducibility of the chronic mild stress paradigm
highlight the need to further explore which paradigms are most successful at inducing
and measuring depressive- and anxiety-like behavior in animal models.
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